Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl.

Moryl N, Bokhari A, Griffo Y, Hadler R, Koranteng L, Filkins A, Zheng T, Horn SD, Inturrisi CE.

Cancer Med. 2019 Dec;8(18):7516-7522. doi: 10.1002/cam4.2479. Epub 2019 Sep 30.

2.

Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients.

Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Horn SD, Inturrisi CE.

J Pain. 2018 Mar;19(3):278-290. doi: 10.1016/j.jpain.2017.11.001. Epub 2017 Nov 14.

3.

Patient-Reported Outcomes and Opioid Use in Outpatients With Chronic Pain.

Witkin LR, Zylberger D, Mehta N, Hindenlang M, Johnson C, Kean J, Horn SD, Inturrisi CE.

J Pain. 2017 May;18(5):583-596. doi: 10.1016/j.jpain.2016.12.018. Epub 2017 Jan 12.

PMID:
28088507
4.

Using Chronic Pain Outcomes Data to Improve Outcomes.

Mehta N, Inturrisi CE, Horn SD, Witkin LR.

Anesthesiol Clin. 2016 Jun;34(2):395-408. doi: 10.1016/j.anclin.2016.01.009. Review.

PMID:
27208717
5.

Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Xu J, Xu M, Brown T, Rossi GC, Hurd YL, Inturrisi CE, Pasternak GW, Pan YX.

J Biol Chem. 2013 Jul 19;288(29):21211-27. doi: 10.1074/jbc.M113.458687. Epub 2013 Jun 11.

6.

Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Bruehl S, Apkarian AV, Ballantyne JC, Berger A, Borsook D, Chen WG, Farrar JT, Haythornthwaite JA, Horn SD, Iadarola MJ, Inturrisi CE, Lao L, Mackey S, Mao J, Sawczuk A, Uhl GR, Witter J, Woolf CJ, Zubieta JK, Lin Y.

J Pain. 2013 Feb;14(2):103-13. doi: 10.1016/j.jpain.2012.10.016. Review.

7.

Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels.

Schierberl K, Hao J, Tropea TF, Ra S, Giordano TP, Xu Q, Garraway SM, Hofmann F, Moosmang S, Striessnig J, Inturrisi CE, Rajadhyaksha AM.

J Neurosci. 2011 Sep 21;31(38):13562-75. doi: 10.1523/JNEUROSCI.2315-11.2011.

8.

Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Reid MC, Bennett DA, Chen WG, Eldadah BA, Farrar JT, Ferrell B, Gallagher RM, Hanlon JT, Herr K, Horn SD, Inturrisi CE, Lemtouni S, Lin YW, Michaud K, Morrison RS, Neogi T, Porter LL, Solomon DH, Von Korff M, Weiss K, Witter J, Zacharoff KL.

Pain Med. 2011 Sep;12(9):1336-57. doi: 10.1111/j.1526-4637.2011.01211.x. Epub 2011 Aug 11.

9.

A true believer's flawed analysis.

Foley KM, Fins JJ, Inturrisi CE.

Arch Intern Med. 2011 May 9;171(9):867-8; author reply 868. doi: 10.1001/archinternmed.2011.166. No abstract available.

PMID:
21555672
10.

Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation.

Hunter DA, Barr GA, Amador N, Shivers KY, Kemen L, Kreiter CM, Jenab S, Inturrisi CE, Quinones-Jenab V.

Synapse. 2011 Jul;65(7):643-51. doi: 10.1002/syn.20890. Epub 2011 Feb 25.

11.

Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base.

Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM.

J Pain. 2010 Sep;11(9):807-29. doi: 10.1016/j.jpain.2010.02.019. Epub 2010 Apr 28.

PMID:
20430701
12.

Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

Gregus AM, Inra CN, Giordano TP 3rd, Costa AC, Rajadhyaksha AM, Inturrisi CE.

Neuroscience. 2010 Aug 11;169(1):475-87. doi: 10.1016/j.neuroscience.2010.03.051. Epub 2010 Mar 29.

13.

N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain.

Weyerbacher AR, Xu Q, Tamasdan C, Shin SJ, Inturrisi CE.

Pain. 2010 Feb;148(2):237-46. doi: 10.1016/j.pain.2009.11.003. Epub 2009 Dec 11.

14.

Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference.

Gregus AM, Tropea TF, Wang Y, Hauck SC, Costa AC, Rajadhyaksha AM, Inturrisi CE.

Neurosci Lett. 2010 Jan 14;468(3):186-9. doi: 10.1016/j.neulet.2009.10.071. Epub 2009 Oct 28.

15.

The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.

Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B.

Neurosci Lett. 2009 Jul 3;457(3):115-9. doi: 10.1016/j.neulet.2009.04.012. Epub 2009 Apr 9.

PMID:
19429175
16.

siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats.

Garraway SM, Xu Q, Inturrisi CE.

J Pain. 2009 Apr;10(4):380-90. doi: 10.1016/j.jpain.2008.09.013. Epub 2009 Jan 29.

17.

Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund's adjuvant-induced pain hypersensitivity.

Xu Q, Garraway SM, Weyerbacher AR, Shin SJ, Inturrisi CE.

J Neurosci. 2008 Dec 24;28(52):14087-96. doi: 10.1523/JNEUROSCI.2406-08.2008.

18.

Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance.

Bogulavsky JJ, Gregus AM, Kim PT, Costa AC, Rajadhyaksha AM, Inturrisi CE.

J Pharmacol Exp Ther. 2009 Feb;328(2):579-87. doi: 10.1124/jpet.108.144121. Epub 2008 Oct 28.

19.

Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn.

Cheng HT, Suzuki M, Hegarty DM, Xu Q, Weyerbacher AR, South SM, Ohata M, Inturrisi CE.

Neuroscience. 2008 Aug 26;155(3):948-58. doi: 10.1016/j.neuroscience.2008.06.024. Epub 2008 Jun 19.

20.

Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice.

Glass MJ, Hegarty DM, Oselkin M, Quimson L, South SM, Xu Q, Pickel VM, Inturrisi CE.

Exp Neurol. 2008 Sep;213(1):57-70. doi: 10.1016/j.expneurol.2008.04.045. Epub 2008 May 20.

21.

A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence.

Klein G, Juni A, Waxman AR, Arout CA, Inturrisi CE, Kest B.

Pharmacol Biochem Behav. 2008 Sep;90(3):447-52. doi: 10.1016/j.pbb.2008.03.030. Epub 2008 Apr 4.

22.

Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.

Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B.

Eur J Pharmacol. 2008 May 31;586(1-3):179-88. doi: 10.1016/j.ejphar.2008.02.035. Epub 2008 Feb 19.

23.

Perioperative pain management in the opioid-tolerant individual.

Gordon D, Inturrisi CE, Greensmith JE, Brennan TJ, Goble L, Kerns RD.

J Pain. 2008 May;9(5):383-7. doi: 10.1016/j.jpain.2008.01.331. Epub 2008 Mar 12. Review. No abstract available.

PMID:
18337186
24.

NIH consensus development statement on hydroxyurea treatment for sickle cell disease.

Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi CE, James AH, Laraque D, Mendez MH, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.

NIH Consens State Sci Statements. 2008 Feb 27-29;25(1):1-30.

25.

The successful use of parenteral methadone in a patient with a prolonged QTc interval.

Sekine R, Obbens EA, Coyle N, Inturrisi CE.

J Pain Symptom Manage. 2007 Nov;34(5):566-9. Epub 2007 Jul 5.

26.
27.

Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test.

Mannino CA, South SM, Quinones-Jenab V, Inturrisi CE.

J Pain. 2007 Apr;8(4):334-42. Epub 2006 Nov 29.

PMID:
17140856
28.

Feeling pain? Who's your daddy....

Pasternak GW, Inturrisi CE.

Nat Med. 2006 Nov;12(11):1243-4. No abstract available.

PMID:
17088889
29.

Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats.

Mannino CA, South SM, Inturrisi CE, Quinones-Jenab V.

J Pain. 2005 Dec;6(12):809-16.

PMID:
16326369
30.

Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats.

Kuba T, Wu HB, Nazarian A, Festa ED, Barr GA, Jenab S, Inturrisi CE, Quinones-Jenab V.

Horm Behav. 2006 Apr;49(4):441-9. Epub 2005 Oct 27.

PMID:
16257405
31.

Pharmacology of methadone and its isomers.

Inturrisi CE.

Minerva Anestesiol. 2005 Jul-Aug;71(7-8):435-7. Review.

32.

The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance.

Inturrisi CE.

Minerva Anestesiol. 2005 Jul-Aug;71(7-8):401-3. Review.

33.

An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.

Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE.

J Pharmacol Exp Ther. 2005 Feb;312(2):834-40. Epub 2004 Sep 23.

PMID:
15388787
34.

MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer rats.

Jenab S, Festa ED, Russo SJ, Wu HB, Inturrisi CE, Quinones-Jenab V.

Brain Res Mol Brain Res. 2003 Oct 7;117(2):237-9.

PMID:
14559159
35.

Parenteral methadone: an essential medication for the treatment of pain.

Manfredi PL, Foley KM, Payne R, Houde R, Inturrisi CE.

J Pain Symptom Manage. 2003 Aug;26(2):687-8. No abstract available.

36.

Chronic opioid exposure produces increased heroin self-administration in rats.

Walker JR, Chen SA, Moffitt H, Inturrisi CE, Koob GF.

Pharmacol Biochem Behav. 2003 May;75(2):349-54.

PMID:
12873626
37.

A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain.

South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, Woolf CJ, Heinemann SF, Inturrisi CE.

J Neurosci. 2003 Jun 15;23(12):5031-40.

38.
39.

The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat.

Zhu H, Jenab S, Jones KL, Inturrisi CE.

Brain Res Dev Brain Res. 2003 May 14;142(2):209-13.

PMID:
12711372
40.

Clinical pharmacology of opioids for pain.

Inturrisi CE.

Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13. Review.

PMID:
12479250
41.
42.

Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.

Jones KL, Zhu H, Jenab S, Du T, Inturrisi CE, Barr GA.

Neuropsychopharmacology. 2002 Mar;26(3):301-10.

43.
44.

Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine.

Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE.

Pain. 1999 May;81(1-2):85-93.

PMID:
10353496
45.

d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.

Davis AM, Inturrisi CE.

J Pharmacol Exp Ther. 1999 May;289(2):1048-53.

PMID:
10215686
46.

Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates.

Collins JJ, Dunkel IJ, Gupta SK, Inturrisi CE, Lapin J, Palmer LN, Weinstein SM, Portenoy RK.

J Pediatr. 1999 Mar;134(3):319-23.

PMID:
10064669
47.

Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia.

Kest B, Jenab S, Brodsky M, Sadowski B, Belknap JK, Mogil JS, Inturrisi CE.

Brain Res. 1999 Jan 23;816(2):381-9.

PMID:
9878841
48.

Acute morphine dependence in mice selectively-bred for high and low analgesia.

Kest B, McLemore GL, Sadowski B, Mogil JS, Belknap JK, Inturrisi CE.

Neurosci Lett. 1998 Nov 6;256(2):120-2.

PMID:
9853718
49.

Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice.

Kest B, Beczkowska I, Franklin SO, Lee CE, Mogil JS, Inturrisi CE.

Brain Res. 1998 Sep 14;805(1-2):131-7.

PMID:
9733948
50.

Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.

Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE.

Eur J Pharmacol. 1998 Mar 12;345(1):47-53.

PMID:
9593593

Supplemental Content

Loading ...
Support Center